Study Comparing Dual-port Trans-subclavian Endoscopic Surgery and Traditional Open Thyroidectomy for Thyroid Tumors Evaluating Safety, Effectiveness, and Recovery Outcomes

What this Trial Is About

Researchers are exploring a new surgical method called Dual-port Trans-subclavian Thyroid Endoscopic Surgery DTS for patients with thyroid tumors. This open-label, non-randomized study compares DTS with the traditional open thyroidectomy COT to assess safety and effectiveness. The trial aims to build evidence on how this new approach may improve surgery outcomes and reduce complications for thyroid cancer and benign tumors. The study involves two groups one undergoing the innovative DTS technique using two small puncture holes to minimize trauma and improve cosmetic results, and the other receiving the standard open thyroid surgery with collar incisions. DTS creates a surgical cavity directly in the neck, potentially reducing tissue damage, pain, and hospital stay compared to the conventional method. Both groups receive surgery as per their treatment choice, and detailed medical data are collected throughout. Participants will be monitored before and after surgery through laboratory tests measuring immune and hormonal markers, pain assessments, and tracking of surgical outcomes like hospital stay length and wound satisfaction over three months. Safety is carefully observed through recording adverse events, vital signs, and pathology exams. The primary measure is the rate of postoperative complications, with follow-up extending up to 100 months to evaluate long-term results.

Dual-port Trans-subclavian Thyroid Endoscopic Surgery